Don’t miss the latest developments in business and finance.

L&T in focus after order win

Image
Capital Market
Last Updated : Sep 16 2014 | 9:15 AM IST

Larsen & Toubro (L&T) after market hours on Monday, 15 September 2014 said that its construction division has won new orders worth Rs 2050 crore across various business segments in August 2014 and September 2014.

Wipro after market hours on Monday, 15 September 2014 said that the company's joint-venture subsidiary, Wipro Arabia has on Monday, 15 September 2014, entered into a strategic partnership with Saudi-based Saudi Electricity Company (SEC), the largest power utility company in the Middle East serving approximately 5 million customers in the Kingdom of Saudi Arabia (KSA). As part of this engagement, Wipro will implement and rollout the plant maintenance and project system functionality of the SAP ERP application for SEC's distribution business line across KSA.

Tata Motors Group global wholesales, including Jaguar Land Rover, fell 9.73% to 73,524 units in August 2014 over August 2013. Global wholesales of all Tata Motors' commercial vehicles and Tata Daewoo range declined 19.6% to 30,536 units in August 2014 over August 2013. Global wholesales of all passenger vehicles slipped 1.11% to 42,988 units in August 2014 over August 2013.

Yes Bank will be watched on reports that the Morgan Stanley Capital International (MSCI) will omit Yes Bank from MSCI's Global Standard Indices. The change will be effective from Thursday, 18 September 2014. MSCI is a leading provider of benchmark indices and risk management analytics products. Many global mutual funds are linked with MSCI indices. Hence, deletion of a stock from the MSCI index leads to outflow of passive funds that use the MSCI index to benchmark their portfolios.

Persistent Systems has entered into a stock purchase agreement with Altizon Systems, a Pune based product company focused on the Internet of Things (IoT), to invest $100,000 in the company by subscribing to the equity shares of Altizon in one or more tranches from time to time. Immediately followed after entering into the above agreement, the company has also remitted its first tranche of investment to Altizon.

Cipla after market hours on Monday, 15 September 2014 announced the signing of a non-exclusive licensing agreement with Gilead Sciences, Inc. for manufacturing and distribution of medicines for the treatment of hepatitis C. Under this licensing agreement, Cipla will be allowed to manufacture and market Sofosbuvir, Ledipasvir in 91 countries including its home markets India and South Africa under Cipla's own brand names. It also covers countries like Egypt which has a high incidence of Hepatitis C. The countries within the agreement account for more than 100 million people living with hepatitis C globally representing 54% of the total global infected population. As per the agreement, Cipla has the option of receiving a technology transfer of the manufacturing process from Gilead.

SeQuent Scientific on Monday, 15 September 2014 announced that Gilead Sciences, Inc. has licensed SeQuent to produce active pharmaceutical ingredients (APIs) sofosbuvir and ledipasvir for treatment of chronic hepatitis C. The announcement was made after market hours on Monday, 15 September 2014. Under the agreement, SeQuent will receive a complete technology pack from Gilead to enable scale up production of the APIs as quickly as possible.

More From This Section

Strides Arcolab on Monday, 15 September 2014 announced that Gilead Sciences Inc has licensed Strides to produce generic sofosbuvir and investigational single tablet regimen of ledipasvir/ sofosbuvir for treatment of chronic hepatitis C. The announcement was made after market hours on Monday, 15 September 2014. Under the agreement, Strides will receive a complete technology transfer of the Gilead manufacturing process for both API and finished product to enable scale up production as quickly as possible.

Cadila Healthcare and Gilead Sciences, Inc. on Monday, 15 September 2014 announced that they have signed a non-exclusive licensing agreement which will allow the generic manufacture of sofosbuvir and investigational single tablet regimen of ledipasvir/ sofosbuvir for distribution in 90 developing countries, including India.

National Buildings Construction Corporation has signed an MoU with National Waqf Development Corporation (NAWADCO), for development of waqf properties all over India as Institutional and commercial projects. NBCC will act as executing agency for the commercial exploitation of the land parcels available with NAWADCO, the company said.

Greaves Cotton said it has permanently closed the manufacturing operations at its construction equipment business plant at Gumidipoondi, Tamil Nadu due to non-viability and to avoid incurring further losses.

Powered by Capital Market - Live News

Also Read

First Published: Sep 16 2014 | 8:36 AM IST

Next Story